What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:VNDA Key Ratios
| Market Cap $ M | 250.76 |
| Enterprise Value $ M | -114.44 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 21.31 |
| Price/Book | 0.47 |
| Price/Sales | 1.25 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 198.00 |
| EPS (TTM) $ | -0.32 |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 2.81 |
| EV-to-EBITDA | 3.52 |
| PEG | -- |
| Shares Outstanding M | 58.32 |
| Net Margin (%) | -9.51 |
| Operating Margin % | -20.46 |
| Pre-tax Margin (%) | -11.53 |
| Quick Ratio | 4.37 |
| Current Ratio | 4.39 |
| ROA % (ttm) | -2.90 |
| ROE % (ttm) | -3.49 |
| ROIC % (ttm) | -12.12 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.70 |
VNDA Number of Guru Trades
VNDA Volume of Guru Trades
Gurus Latest Trades with NAS:VNDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VNDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vanda Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VNDA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers